According to a new report North America Coronary stents Market, published by KBV research, the North America Coronary stents Market would witness market growth of 7.2% CAGR during the forecast period (2018 – 2024).
The Drug-eluting stents (DES) market would dominate the North America Coronary Stents Market by Product Type by 2024, growing at a CAGR of 7 % during the forecast period. The Bare-Metal Stents market is expected to witness a CAGR of 6.9% during (2018 - 2024). Additionally, The Bioresorbable Vascular Scaffold market is expected to witness highest CAGR of 9.2% during (2018 - 2024).
The USA market dominated the North America Slotted Tubular Surface Market by Country in 2017. The Canada market is expected to witness a CAGR of 8.7% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 9% during (2018 - 2024).
The Micro porous Surface market dominated the Mexico Coronary Stents Market by Polymer Free Drug Eluting Stents Type in 2017, and would achieve a market value of $51.4 million by 2024. The Nanoporous Surface market is expected to witness a CAGR of 9.9% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/north-america-coronary-stents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
By Product Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Related Report:
Europe North America Coronary Stents Market
Unique Offerings 
